Mouse model to aid Zika vaccine testing
Researchers have established a new mouse model for testing vaccines and therapeutics to fight the Zika virus.
Archives for April 5, 2016
MannKind waves 'au revoir' to Sanofi as it regains Afrezza rights
The rights to inhaled insulin drug Afrezza have returned to Mannkind Corporation, three months after Sanofi terminated its commercialisation deal.
inVentiv preps for $100m IPO
US CRO inVentiv Health has signaled its intention to go public by filing an S1 with the Securities and Exchange Commission (SEC) last night.
Charles River files with SEC as WIL Research acquisition is finalized
Charles River Laboratories has completed its previously announced acquisition of WIL Research for approximately $585m in cash.
Dispatches from DCAT Week
'Chindia' drug substance market not to be discounted
China and India are causing a “tsunami” in the drug substance market – yet significant hurdles may bring fine chemical outsourcing back to the West.
Daiichi Sankyo: looming Benicar patent loss and large molecule focus prompted plant closure
Closure of its Benicar intermediates plant was prompted by impending US patent loss and a decision to focus on large molecule drugs says Daiichi Sankyo.
Lilly takes to continuous manufacturing with $40m Irish investment
Eli Lilly will pump €35m ($40m) into a new facility in Ireland focused on the continuous manufacturing of its APIs.
Pfizzles out: Pfizer pulls out of Allergan merger citing US tax clampdown
Pfizer Inc will remain a US firm after calling off a proposed $160bn merger with Ireland’s Allergan Plc.
Quintiles talks digital tech, patient centricity, practicality
Digital health is continuing to play an influential role in the future of clinical research, but progression should be balanced with practicality, says Quintiles.